Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3954
-0.0056 (-1.40%)
At close: Apr 3, 2025, 4:00 PM
0.4243
+0.0289 (7.31%)
After-hours: Apr 3, 2025, 7:55 PM EDT

Bolt Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-63.12-69.2-88.1-98.59-60.73
Upgrade
Depreciation & Amortization
1.781.851.671.190.61
Upgrade
Loss (Gain) From Sale of Assets
-0.07--0.11-
Upgrade
Asset Writedown & Restructuring Costs
1.47----
Upgrade
Loss (Gain) From Sale of Investments
-2.62-4.490.182.650.03
Upgrade
Stock-Based Compensation
7.419.229.588.51.42
Upgrade
Other Operating Activities
2.32.953.238.5613.64
Upgrade
Change in Accounts Payable
-4.88-3.412.776.682.88
Upgrade
Change in Unearned Revenue
-4.67-3.61-2.1615.57-0.07
Upgrade
Change in Other Net Operating Assets
1.12-2.85-3.66-1.74-5.1
Upgrade
Operating Cash Flow
-61.29-69.53-76.5-57.07-47.31
Upgrade
Capital Expenditures
-0.04-0.21-1.95-2.34-3.26
Upgrade
Sale of Property, Plant & Equipment
0.15----
Upgrade
Investment in Securities
57.4771.2459.82-229.86-17.33
Upgrade
Investing Cash Flow
57.5871.0457.86-232.2-20.59
Upgrade
Issuance of Common Stock
0.110.250.5259.210.29
Upgrade
Other Financing Activities
-----1.97
Upgrade
Financing Cash Flow
0.110.250.5311.1139.6
Upgrade
Net Cash Flow
-3.611.77-18.1421.84-28.3
Upgrade
Free Cash Flow
-61.33-69.73-78.46-59.4-50.57
Upgrade
Free Cash Flow Margin
-797.53%-885.36%-1369.47%-4714.60%-21891.78%
Upgrade
Free Cash Flow Per Share
-1.61-1.84-2.10-1.79-24.05
Upgrade
Levered Free Cash Flow
-37.54-39.47-46.18-41.99-29.22
Upgrade
Unlevered Free Cash Flow
-37.54-39.47-46.18-41.99-29.22
Upgrade
Change in Net Working Capital
4.042.71-0.98-8.65-2.75
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q